CNR2 (GeneID: 1269) | Homo sapiens
Description: cannabinoid receptor 2 [Source:HGNC Symbol;Acc:HGNC:2160]
Synonyms: CB-2, CX5, CB2
Other ID(s): ENSG00000188822, HGNC:2160
Protein Accession Numbers: ENST00000536471, ENST00000374472, NP_001832
Statistics: ClinVar(3) COSMIC(391) PTM(13)
ClinVar Pathogenicity of Variations help
100%10010090908080707060605050404030302020101000
Download SVG
Download PNG
Download CSV

∙ Please click the name of species for the protein accession number used in the alignment.
∙ A p letter used as a pointer to positions of post translational modifications in human.
∙ Protein domains illustrated above belong to Homo sapiens (Human).
∙ ClinVar stacked bar chart represents whole protein isoforms of the gene. Please, check the other protein isoforms of the gene below.
∙ If more than one transcripts below are active (with blue background color), it means all the active transcripts have the same sequence.
ENST00000374472 You are here now! ENST00000536471 You are here now! NP_001832 You are here now!


import_contactsClinVar Data

healinggnomAD
10010090908080707060605050404030302020101000

placePost-translational Modifications (PTMs)
85%15%10010090908080707060605050404030302020101000
Phosphorylation
Ubiquitination
Download SVG
Download PNG
Download CSV

blur_onCatalogue of Somatic Mutations in Cancer (COSMIC)
10%30%59%10010090908080707060605050404030302020101000
Deletion - Frameshift
Substitution - Coding Silent
Substitution - Missense
Substitution - Nonsense
Unknown
Download SVG
Download PNG
Download CSV

format_align_centerProtein Domains (PFAM)
Pfam Domain filter_list Domain Name filter_list Description filter_list Positions filter_list Clan filter_list Clan Name filter_list Organism filter_list
NO RESULT FOUND
PF00001 7tm_1 7 transmembrane receptor (rhodopsin family) 50-299 CL0192 GPCR_A Homo sapiens

view_listList of the diseases from DisGeNET
Disease Name filter_list Disease Category filter_list DSI* filter_list DPI** filter_list
Alcoholic Intoxication, Chronic Chemically-Induced Disorders ; Mental Disorders ; 0.554 0.621
Atherosclerosis Cardiovascular Diseases ; 0.554 0.621
Bipolar Disorder Mental Disorders ; 0.554 0.621
Malignant neoplasm of breast Neoplasms ; Skin and Connective Tissue Diseases ; 0.554 0.621
Mental Depression Behavior and Behavior Mechanisms ; 0.554 0.621
Endogenous depression Mental Disorders ; 0.554 0.621
Depressive disorder Mental Disorders ; 0.554 0.621
Hyperalgesia Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; 0.554 0.621
Immune System Diseases Immune System Diseases ; 0.554 0.621
Leukemia, Myelocytic, Acute Neoplasms ; 0.554 0.621
Liver Cirrhosis Digestive System Diseases ; 0.554 0.621
Marijuana Abuse Chemically-Induced Disorders ; Mental Disorders ; 0.554 0.621
Melancholia Mental Disorders ; 0.554 0.621
Acute Myeloid Leukemia, M1 Neoplasms ; 0.554 0.621
Pancreatic Neoplasm Neoplasms ; Digestive System Diseases ; Endocrine System Diseases ; 0.554 0.621
Pancreatitis Digestive System Diseases ; 0.554 0.621
Secondary Parkinson Disease Nervous System Diseases ; 0.554 0.621
Schizophrenia Mental Disorders ; 0.554 0.621
Unipolar Depression Mental Disorders ; 0.554 0.621
Alcohol abuse Chemically-Induced Disorders ; Mental Disorders ; 0.554 0.621
Depressive Syndrome Mental Disorders ; 0.554 0.621
Fibrosis, Liver Digestive System Diseases ; 0.554 0.621
Depression, Neurotic Mental Disorders ; 0.554 0.621
Malignant neoplasm of pancreas Neoplasms ; Digestive System Diseases ; Endocrine System Diseases ; 0.554 0.621
Allodynia Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; 0.554 0.621
Breast Carcinoma Neoplasms ; Skin and Connective Tissue Diseases ; 0.554 0.621
Hyperalgesia, Primary Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; 0.554 0.621
Hyperalgesia, Secondary Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; 0.554 0.621
Tactile Allodynia Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; 0.554 0.621
Hyperalgesia, Thermal Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; 0.554 0.621
Parkinson Disease, Secondary Vascular Nervous System Diseases ; 0.554 0.621
Atherosclerotic Parkinsonism Nervous System Diseases ; 0.554 0.621
Mammary Neoplasms, Human Neoplasms ; Skin and Connective Tissue Diseases ; 0.554 0.621
Mammary Neoplasms Neoplasms ; Skin and Connective Tissue Diseases ; 0.554 0.621
Atherogenesis Cardiovascular Diseases ; 0.554 0.621
Acute Myeloid Leukemia (AML-M2) Neoplasms ; 0.554 0.621
Mechanical Allodynia Nervous System Diseases ; Pathological Conditions, Signs and Symptoms ; 0.554 0.621
Cannabis use N/A 0.554 0.621
NO RESULT FOUND
feedback

Classification of Clinicial Significance of ClinVar Data
Send a feedback about the results.